150 related articles for article (PubMed ID: 2872244)
1. Effects of esmolol on patients with left ventricular dysfunction.
Iskandrian AS; Bemis CE; Hakki AH; Panidis I; Heo J; Toole JG; Hua TA; Allin D; Kane-Marsch S
J Am Coll Cardiol; 1986 Jul; 8(1):225-31. PubMed ID: 2872244
[TBL] [Abstract][Full Text] [Related]
2. Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapy.
Kirshenbaum JM; Kloner RF; McGowan N; Antman EM
J Am Coll Cardiol; 1988 Sep; 12(3):773-80. PubMed ID: 2900259
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of esmolol, an ultrashort-acting beta blocker.
Askenazi J; MacCosbe PE; Hoff J; Turlapaty P; Hua TA; Laddu A
J Clin Pharmacol; 1987 Aug; 27(8):567-73. PubMed ID: 2888793
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with esmolol, a short-acting beta-adrenergic blocker in cardiac arrhythmias and myocardial ischemia.
Sung RJ; Blanski L; Kirshenbaum J; MacCosbe P; Turlapaty P; Laddu AR
J Clin Pharmacol; 1986 Mar; 26(S1):A15-A26. PubMed ID: 2870082
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the potassium channel blocker tedisamil with the beta-adrenoceptor blocker esmolol and the calcium antagonist gallopamil in patients with coronary artery disease.
Mitrovic V; Oehm E; Thormann J; Pitschner H; Haberbosch W
Clin Cardiol; 1998 Jul; 21(7):492-502. PubMed ID: 9669058
[TBL] [Abstract][Full Text] [Related]
6. [The hemodynamic effects of a treatment with beta-receptor blockers during coronary surgery. A comparison between acebutolol and esmolol].
Kling D; Boldt J; Zickmann B; Dapper F; Hempelmann G
Anaesthesist; 1990 May; 39(5):264-8. PubMed ID: 1972611
[TBL] [Abstract][Full Text] [Related]
7. Control of tachycardia and hypertension following coronary artery bypass graft surgery: efficacy and haemodynamic effects of esmolol.
Tempe DK; Mulchandani P; Tandon MS; Mehta N; Tomar AS; Banerjee A; Khanna SK
Indian Heart J; 1999; 51(3):294-300. PubMed ID: 10624069
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of intravenous diltiazem with impaired left ventricular function.
Materne P; Legrand V; Vandormael M; Collignon P; Kulbertus HE
Am J Cardiol; 1984 Oct; 54(7):733-7. PubMed ID: 6486022
[TBL] [Abstract][Full Text] [Related]
9. Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemia.
Kirshenbaum JM; Kloner RA; Antman EM; Braunwald E
Circulation; 1985 Oct; 72(4):873-80. PubMed ID: 2863013
[TBL] [Abstract][Full Text] [Related]
10. Intravenous esmolol is well tolerated in elderly patients with heart failure in the early phase of non-ST elevation myocardial infarction.
Koutouzis M; Nikolidakis S; Grigoriadis A; Koutsogeorgis D; Kyriakides ZS
Drugs Aging; 2006; 23(8):673-80. PubMed ID: 16964989
[TBL] [Abstract][Full Text] [Related]
11. Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias.
Gray RJ; Bateman TM; Czer LS; Conklin CM; Matloff JM
J Am Coll Cardiol; 1985 Jun; 5(6):1451-6. PubMed ID: 2860148
[TBL] [Abstract][Full Text] [Related]
12. Ultra short-acting intravenous beta-adrenergic blockade as add-on therapy in acute unstable angina.
Barth C; Ojile M; Pearson AC; Labovitz AJ
Am Heart J; 1991 Mar; 121(3 Pt 1):782-8. PubMed ID: 1672051
[TBL] [Abstract][Full Text] [Related]
13. The safety and efficacy of esmolol during myocardial revascularization.
Girard D; Shulman BJ; Thys DM; Mindich BP; Mikula SK; Kaplan JA
Anesthesiology; 1986 Aug; 65(2):157-64. PubMed ID: 3526984
[TBL] [Abstract][Full Text] [Related]
14. Right ventricular dysfunction following cold potassium cardioplegia.
Christakis GT; Fremes SE; Weisel RD; Ivanov J; Madonik MM; Seawright SJ; McLaughlin PR
J Thorac Cardiovasc Surg; 1985 Aug; 90(2):243-50. PubMed ID: 3875003
[TBL] [Abstract][Full Text] [Related]
15. Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy.
Mooss AN; Hilleman DE; Mohiuddin SM; Hunter CB
Ann Pharmacother; 1994 Jun; 28(6):701-3. PubMed ID: 7919552
[TBL] [Abstract][Full Text] [Related]
16. Use of esmolol in hypertension after cardiac surgery.
Gray RJ; Bateman TM; Czer LS; Conklin C; Matloff JM
Am J Cardiol; 1985 Oct; 56(11):49F-56F. PubMed ID: 2864849
[TBL] [Abstract][Full Text] [Related]
17. Ventricular systolic and diastolic impairment during pacing-induced myocardial ischemia in coronary artery disease: simultaneous hemodynamic, electrocardiographic, and radionuclide angiographic evaluation.
Iskandrian AS; Bemis CE; Hakki AH; Heo J; Kimbiris D; Mintz GS
Am Heart J; 1986 Aug; 112(2):382-91. PubMed ID: 3017084
[TBL] [Abstract][Full Text] [Related]
18. Effects of intravenous infusion of esmolol and propranolol on biventricular performance at rest and during exercise as assessed by quantitative radionuclide angiography.
Iskandrian AS; Hakki AH; Laddu A; Steck J; Saunders R; Kane-Marsch S; Morganroth J
Am J Cardiol; 1985 May; 55(11):1287-92. PubMed ID: 3993558
[TBL] [Abstract][Full Text] [Related]
19. Comparison of esmolol and nitroprusside for acute post-cardiac surgical hypertension.
Gray RJ; Bateman TM; Czer LS; Conklin C; Matloff JM
Am J Cardiol; 1987 Apr; 59(8):887-91. PubMed ID: 2881481
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock: a pilot study.
Levy B; Fritz C; Piona C; Duarte K; Morelli A; Guerci P; Kimmoun A; Girerd N
Crit Care; 2021 Jan; 25(1):21. PubMed ID: 33413583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]